| Code | 9025C | ||||||||||
| MA number | 31/0310/18-S | ||||||||||
| Product Form: | tbl 50x1x10 mg/40 mg (blis.PVC/Al/OPA/Al-jednotliv.bal) | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| Therapeutic Class: | 31 - HYPOLIPIDAEMICA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 24 | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 20.09.2018 |
| Pediatric posology: | Yes |
| Pediatric warnings: | Yes |
| PIL: |
PIL_Glezisim tablety_10.2023.pdf
|
| SPC: |
SPC_Glezisim tablety_10.2023.pdf
|
| Safety feature | Yes |
| Data update: | 16.10.2023 |
